Supporting pharmaceutical manufacturing in Kenya
Introduction
The overall objective of the feasibility study is to assess the viability of establishing a pharmaceutical manufacturing park in Kenya, with a focus on maximising national development outcomes and attracting long-term private investment under a transparent and inclusive governance framework.
The health sector in most African countries, including Kenya, is undergoing significant transformation due to the New Public Health Order issued by the African Union and driven by overall economic development and a growing middle class. The pan-African reform agenda was issued in 2021 (after covid-19), emphasising pharmaceutical and vaccine production.
Facts
SDG in focus
No Poverty
End poverty in all its forms everywhere.
Decent Work and Economic Growth
Promote sustained, inclusive and sustainable economic growth, full and productive employment and decent work for all.
Reduced Inequalities
Reduce inequality within and among countries.
Value creation
Expected Impact
The project is expected to contribute to enhanced supply of essential medicines, to create jobs and build local capacity in pharmaceutical manufacturing, and to promote growth in the manufacturing sector.
Whistleblowing and Grievance Mechanisms
If you have concerns regarding a Project Accelerator-supported project or activity, you can report them through Swedfund's whistleblowing and grievance mechanisms. These channels are available to affected stakeholders, workers, contractors and other interested parties. 🔹 Link in website footer.
Other projects within
Healthcare